Questions about AstraZeneca jab linger
Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against COVID-19 are more frequent …
Home »
Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against COVID-19 are more frequent …
(HealthDay)—Patients who survive severe COVID-19 after being hospitalized are not necessarily home-free upon discharge, new research warns. After tracking outcomes …